Cite

    Casey Quinn et al.. “Current challenges for assessing the long-term clinical benefit of cancer immunotherapy: a multi-stakeholder perspective.” Journal for immunotherapy of cancer, vol. 8, no. 2, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127563996.0x00002c